LUX-DxTM Insertable Cardiac Monitor Remote Programming and Performance Study

About this Study

The purpose of this study is to collect information on how the LUX-Dx ICM system performs in patients who have different kinds of medical conditions that put them at risk for potentially harmful irregular or abnormal heart beats

Sponsor Protocol ID:C2045
IRB Number:2021-1100
Actively Enrolling
Early Phase 1
March 21, 2022
Eligibility Criteria
18 years old
Both Male and Female

Inclusion Criteria
  • Patient is indicated to be implanted with LUX-Dx ICM forĀ  Cryptogenic stroke, syncope (fainting), or AF, Post-AF ablation, suspected AF
  • Patient is willing to enroll and be monitored in LATITUDE Clarity
  • Patient is willing and able to be followed remotely via patient mobile app
  • Patient is willing and capable of providing informed consent
  • Patient is 18 years or above, or legal age to give informed consentĀ 

Exclusion Criteria
  • Patient in indicated for implantation of, or is currently implanted with an active implantable cardiac device
  • Patient cannot tolerate a subcutaneous, chronically inserted device due to medical condition
  • Patient has life expectancy of less than 12 months
  • Patient is pregnant at time of study enrollment
  • Patient is currently enrolled in another clinical study including observational studies/registries

Categories Click category to view its trials.
Heart Health
Participating Locations
Northeast Jackson - UMMC
Pavilion - UMMC
University Heart - UMMC
Contact Information
Contact Name: Memrie Cochran
Phone Number: 601-984-2667
Principal Investigator:Hamilton, James H, M.D.
How to participate in our Clinical Trials